Pacific Biosciences of California (PACB) Options Chain & Prices $1.32 +0.04 (+3.13%) Closing price 04:00 PM EasternExtended Trading$1.33 +0.01 (+0.45%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Options Chain Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest PACB Put and Call Options List 1/21/2028 3/19/2027 1/15/2027 12/18/2026 10/16/2026 9/18/2026 Options Date Put and Call Options Put Options Call Options Options Type All In The Money Out of The Money Moneyness With Volume Without Volume All Volume Strike Price Min Strike Price Max Export ExpiresStrike PriceClose PricePut/CallVolumeVolume AskVolume BidOpen InterestImplied VolatilityDeltaTrades9/18/2026$1.50$0.050Call52 - 5110727(-3)112.19% (+7.89%)0.292923End-of-day options data provided by Trade Alert and Intrinio. Related Companies and Tools Related Companies 10x Genomics Options Azenta Options CryoPort Options OmniAb Options Cytek Biosciences Options Ginkgo Bioworks Options Simulations Plus Options Standard BioTools Options Codexis Options Quantum-Si Options Options Chain Tools Short Interest TrackerShort Interest IncreasesShort Interest DecreasesUnusual Call VolumeUnusual Put Volume This page (NASDAQ:PACB) was last updated on 9/2/2026 by MarketBeat.com Staff. From Our PartnersRickards Predicts: Trump to buy tiny $2 stock?Jim Rickards believes the Trump administration is about to take a direct stake in a $2 stock sitting on the la...Paradigm Press | SponsoredJon Najarian's #1 Energy Trade for 2026Elon Musk just built the largest private power network in American history. Hall of Fame Trader Jon Najarian s...Banyan Hill Publishing | SponsoredMusk says UBI is coming. I say it's already here.Elon Musk says AI could make money irrelevant by 2036. One income program already exists today, funded not by ...Freedom Financial | SponsoredNvidia insiders sold $1.8 billion. Here is my next move.Nvidia insiders sold $1.8 billion in stock last year, with zero buys. Jensen Huang alone made 42 consecutive s...The Oxford Club | SponsoredWhat the Mainstream Media Gets Wrong About IPO InvestingJason Bodner spent nearly two decades helping IPOs go to market. Now he says an overlooked group of companies ...Brownstone Research | SponsoredThis Gold Fund Could Outyield Newmont With Far Less CapitalPut $24,000 into Newmont and you'd collect about $240 a year - a 1% yield that barely covers groceries. A l...Investors Alley | SponsoredThese 3 Stocks Could Soar as Sam Altman Announces New Venture After OpenAIElon Musk calls it the most disruptive force in history. Sam Altman is reportedly preparing a new venture afte...Stansberry Research | SponsoredBuy this stock tomorrow morningA new strategy called Sell This, Buy That aims to help investors rotate out of overpriced AI stocks before a p...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pacific Biosciences of California, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pacific Biosciences of California With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
